Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Mirabegron (E.R.) 25mg
Therapeutic Category
General and OTC medicines, Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹299/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Miratyle 25 Tablet contains Mirabegron (E.R.) 25mg, a beta-3 adrenergic agonist primarily used to manage symptoms of overactive bladder (OAB). It helps improve bladder control by relaxing the bladder muscles, thereby increasing its capacity to store urine and reducing the frequency and urgency of urination.
This extended-release formulation ensures sustained therapeutic action throughout the day, providing consistent relief from OAB symptoms. Miratyle 25 Tablet is particularly beneficial for individuals experiencing frequent urination, sudden urges to urinate, or episodes of urinary incontinence.
Mirabegron offers an innovative approach to OAB management by targeting beta-3 adrenergic receptors in the bladder. Unlike anticholinergic medications, it has a lower risk of causing dry mouth and constipation, making it a suitable option for long-term treatment. The tablet is designed for easy administration, with once-daily dosing ensuring convenience and compliance.
Common side effects include increased blood pressure, headache, nasopharyngitis, and urinary tract infections. Rarely, dizziness or gastrointestinal discomfort may occur.
For the treatment of overactive bladder (OAB) symptoms, including urgency, frequency, and urge urinary incontinence.
Use only under medical supervision. Inform your doctor if you have high blood pressure, severe kidney or liver impairment, or are pregnant or breastfeeding. Adhere to the prescribed dosage.
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.
Composition : Mirabegron (50mg) + Solifenacin (5mg)
Composition : Mirabegron 50mg + Solifenacine Succinate I.P. 5mg
Composition : Mirabegron (50mg)
Composition : Mirabegron (E.R.) 25mg
Composition : Mirabegron (E.R.) 50mg
Composition : Piracetam (800mg) Tablet
Composition : Piracetam (200mg)
Composition : Levetiracetam (100mg) Injection
Composition : Levetiracetam (1000mg) Infusion
Composition : Levetiracetam (1000mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Mirabegron 25 mg Extended Release (ER) Tablet is a urology medication used for the management of overactive bladder (OAB) symptoms such as urinary urgency, frequent urination, and urge incontinence. It works as a beta-3 adrenergic agonist, helping relax the bladder muscle and increasing its storage capacity, thereby reducing sudden urges to urinate. It is widely prescribed in the urology and geriatric care segment.
Medical distributors and wholesalers can benefit from consistent demand from urologists, gynecologists, and general physicians, especially due to the increasing prevalence of bladder dysfunction in the aging population. This condition requires long-term therapy, ensuring repeat prescriptions and stable sales growth.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in urology, gynecology, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from growing geriatric population, increasing awareness of bladder health, and strong specialist-driven prescriptions, making it a stable, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in urology and chronic care products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the urology and geriatric healthcare segment.